Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells

Journal of Clinical Investigation

Volumn 93, Issue 1, 1994, Pages 81-88

  Visentin, Gian P ^a   Ford, Sheila E ^b   Scott, J Paul ^b   Aster, Richard H ^b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

ELISA; flow cytometry; glycosaminoglycan; IgG; IgM

Indexed keywords

HEPARIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; THROMBOCYTE FACTOR 4;

ADULT; AGED; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOSIS; UMBILICAL VEIN;

EID: 0028009642     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI116987     Document Type: Article

References (44)

1. Weismann, R. E., and R. W. Tobin. 1958. Arterial embolism occurring during systemic heparin therapy. Arch. Surg. 76:219-227.
2. Roberts, B., F. E. Rosato, and E. F. Rosato. 1964. Heparin: a cause of arterial emboli? Surgery (St. Louis). 55:803.
3. Warkentin, T. E., and J. G. Kelton. 1991. Heparin-induced thrombocytopenia. Prog. Hemostasis Thromb. 10:1-34.
4. Edson, J. R. 1992. Heparin-induced thrombocytopenia. J. Lab. Clin. Med. 120:355-356.
5. Chong, B. H., W. R. Pitney, and P. A. Castaldi. 1982. Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG synthesis that induces thromboxane synthesis and platelet aggregation. Lancet. ii:1246-1248.
6. Kelton, J. G., D. Sheridan, A. Santos, J. Smith, K. Steeves, C. Smith, C. Brown, and W. G. Murphy. 1988. Heparin-induced thrombocytopenia: laboratory studies. Blood. 72:925-930.
7. Green, D., K. Harris, N. Reynolds, M. Roberts, and R. Patterson. 1978. Heparin immune thrombocytopenia: evidence for heparin-platelet complex as the antigenic determinate. J. Lab. Clin. Med. 91:167.
8. Greinacher, A., I. Michels, and C. Mueller-Eckhardt. 1992. Heparin-associated thrombocytopenia: the antibody is not heparin specific. Thromb. Haemostasis. 67:545-549.
9. Amiral, J., F. Bridey, M. Dreyfus, A. M. Vissac, E. Fressinaud, M. Wolf, and D. Meyer. 1992. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb. Haemostasis. 68:95-96 (letter).
10. Vu, T. K. H., D. T. Hung, V. I. Wheaton, and S. R. Coughlin. 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1057-1068.
11. Vu, T. K. H., V. I. Wheaton, D. T. Hung, I. Charo, and S. R. Coughlin. 1991. Domain specifying thrombin-receptor interaction. Nature (Lond.). 353:674-677.
12. Sheridan, D., C. Carter, and J. G. Kelton. 1986. A diagnostic test for heparin-induced thrombocytopenia. Blood. 67:27-30.
13. Thompson, A. R., and R. B. Counts. 1976. Removal of heparin and protamine from plasma. J. Lab. Clin. Med. 88:922-929.
14. Medici, I., A. DiMartino, G. Chela, L. Callegaro, and M. Prosdocimi. 1989. Improved method for purification of human platelet factor 4 by affinity and ion-exchange chromatography. Thromb. Res. 54:277-287.
15. Tomiyama, Y., T. J. Kunicki, T. F. Zipf, S. B. Ford, and R. H. Aster. 1992. Response of human platelets to activating monoclonal antibodies: importance of FcγRII (CD32) phenotype and a level of expression. Blood. 80:2261-2268.
16. Visentin, G. P., K. Wolfmeyer, P. J. Newman, and R. H. Aster. 1990. Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion (Phila.). 30:694-700.
17. Barbieri, B., G. Balconi, E. Dejana, and M. B. Donati. 1981. Evidence that vascular endothelial cells can induce the retraction of fibrin clots. Proc. Soc. Exp. Biol. Med. 68:204-207.
18. Balconi, G., and E. Dejana. 1986. Cultivation of endothelial cells: limitations and perspectives. Med. Biol. (Helsinki). 64:231-245.
19. Ryo, R., R. T. Proffitt, M. E. Poger, R. O'Bear, and T. F. Deuel. 1980. Platelet factor 4 antigen in megakaryocytes. Thromb. Res. 17:645-652.
20. Zucker, M. B., and I. R. Katz. 1991. Platelet factor 4: production, structure, and physiologic and immunologic action. Proc. Soc. Exp. Biol. Med. 198:693-702.
21. Poncz, M., S. Surrey, P. LaRocco, M. J. Weiss, E. F. Rappaport, T. M. Conway, and E. Schwartz. 1987. Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line. Blood. 69:219-223.
22. Barone, A. D., J. Ghrayeb, U. Hammerling, M. B. Zucker, and G. J. Thorbecke. 1988. The expression in E coli of recombinant human platelet factor 4, a protein with immunoregulatory activity. J. Biol. Chem. 263:8710-8715.
23. St. Charles, R., D. A. Walz, and B. F. Edwards. 1989. The three-dimensional structure of bovine platelet factor 4 at 3.0A resolution. J. Biol. Chem. 264:2092-2099.
24. Stuckey, J. A., R. St. Charles, and B. F. P. Edwards. 1992. A model of the platelet factor 4 complex with heparin. Proteins Struct. Funct. Genet. 14:277-287.
25. Loscalzo, J., B. Melnick, and R. I. Handin. 1985. The interaction of platelet factor 4 and glycosaminoglycans. Arch. Biochem. Biophys. 241:446-455.
26. Nieduszynski, I. 1989. General physical properties of heparin. In Heparin: Chemical and Biological Properties, Clinical Applications. D. A. Lane and U. Lindahl, editors. CRC Press, Inc., Boca Raton, FL. 51-63.
27. Visentin, G. P., P. J. Newman, and R. H. Aster. 1991. Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. Blood. 77:2668-2676.
28. Wahl, T. O., D. A. Lipschitz, and D. J. Stechschulte. 1978. Thrombocytopenia associated with antiheparin antibody. J. Am. Med. Assoc. 240:2560-2562.
29. Favoloro, E. J., E. Bernal-Hoyos, T. Exner, and J. Koutts. 1992. Heparin-induced thrombocytopenia: laboratory investigation and confirmation of diagnosis. Pathology. 24:177-183.
30. McCrae, K. R., S. J. Shattil, and D. B. Cines. 1990. Platelet activation induces increased Fc gamma receptor expression. J. Immunol. 144:3920-3927.
31. Chong, B. H., R. L. Pilgrim, M. A. Cooley, and C. N. Chesterman. 1993. Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia. Blood. 81:988-993.
32. Marcum, J. A., and R. D. Rosenberg. 1989. The biochemistry, cell biology, and pathophysiology of anticoagulantly active heparin-like molecules of the vessel wall. In Heparin: Chemical and Biological Properties Clinical Applications. D. A. Lane and U. Lindal, editors. CRC Press, Inc., Boca Raton, FL. 275-294.
33. Busch, C., J. Dawes, D. S. Pepper, and A. Wasteson. 1980. Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb. Res. 19:129-137.
34. Ryback, M. E., M. A. Gimbrone, Jr., P. F. Davies, and R. I. Handin. 1989. Interaction of platelet factor 4 with cultured vascular endothelial cells. Blood. 73:1534-1539.
35. Dawes, J., C. W. Pumphrey, K. M. McLaren, C. V. Prowse, and D. S. Pepper. 1982. The in vivo release of human platelet factor 4 by heparin. Thromb. Res. 27:65-76.
36. Rao, A. K., S. Niewiarowski, P. James, J. C. Holt, M. Harris, B. Elfenbein, and C. Bastl. 1983. Effect of heparin on the in vivo release and clearance of human platelet factor 4. Blood. 61:1208-1214.
37. O'Brien, J. R., M. D. Etherington, and M. Pashley. 1984. Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilizable pool of PF4 in health and atherosclerosis. Thromb. Haemostasia. 51:354-357.
38. Cines, D. B., A. Tomaski, and S. Tannenbaum. 1987. Immune endothelial-cell injury in heparin-associated thrombocytopenia. N. Engl. J. Med. 316:581-589.
39. Foresti, V., G. Guareschi, A. Pediconi, N. Scolari, A. Vismara, and F. Confalonieri. 1988. Platelet aggregating IgG without antibodies to endothelial cells in a case of heparin-induced thrombocytopenia with thrombotic complication. Haematologica. 73:125-7.
40. Eika, C. 1972. The platelet aggregating effect of eight commercial heparins. Scand. J. Haematol. 9:480.
41. Zucker, M. B. 1974. Effect of heparin on platelet function. Thromb. Diath. Haemorrh. 33:63-65.
42. Huang, S. S., J. S. Huang, and T. F. Deuel. 1982. Proteoglycan carrier of human platelet factor 4. J. Biol. Chem. 257:11546.
43. Holt, J. C., and S. Niewiarowski. 1985. Biochemistry of alpha-granule proteins. Semin. Hematol. 22:151-163.
44. Handin, R. I., and H. J. Cohen. 1976. Purification and binding properties of human platelet factor 4. J. Biol. Chem. 251:4273-4282.